Exagen Inc.
A medical diagnostics company, Exagen makes blood tests that help rheumatologists tell apart autoimmune conditions like lupus and rheumatoid arthritis. Its flagship product, AVISE CTD, is processed in a single lab in Vista, California, with results typically ready in about five business days. Founded in 2002, the company grows its line of AVISE-branded tests, and the "CTD" in its flagship test's name stands for connective tissue disease—the family of illnesses it helps doctors sort out.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| Parian Ultreia LP | 13GPassive | 5.3% | 1.29M | May 27, 2026 |
| Chernett Jorey | 13G/APassive | 9.9% | 2.41M | May 20, 2026 |
| RTW Investments, LP | 13G/APassive | 4.9% | 1.15M | Feb 17, 2026 |
| Roderick Wong | 13G/APassive | 4.9% | 1.15M | Feb 17, 2026 |
| NMSIC Co-Investment Fund, L.P. | 13G/APassive | 6.04% | 1.37M | Feb 11, 2026 |
| Sun Mountain Capital Partners, L.L.C. | 13G/APassive | 6.04% | 1.37M | Feb 11, 2026 |
| LYTTON LAURENCE W | 13G/APassive | 1% | 216.8K | Aug 14, 2025 |
| Cowen Financial Products LLC | 13G/APassive | 5% | 891.4K | May 12, 2025 |